“The vaccine has been named Corbevax and it is based on a traditional protein-based technology that has been safely used for decades.
Like other COVID-19 vaccines, Corbevax focuses on the coronavirus spike protein, but instead of using mRNA
to direct our cells to produce those spike proteins internally it delivers lab-grown spike proteins to the body. “
“In late 2020 the US research team developing the vaccine joined forces with India-based pharma company Biological E to begin clinical trials and establish manufacturing capacity.
Across 2021 those clinical trials included several thousand participants and ultimately found Corbevax
to be safe and effective at generating robust immune responses to SARS-CoV-2. “
“The trial data was compared to an already approved vaccine called Covishield (the Indian-made version of Astrazeneca’s well-known COVID-19 vaccine).
Corbevax generated significantly fewer adverse effects than Covishield and produced superior immune responses.”
The spike protein is the problem. I’ll pass. And again wait till the effects are made clear.